| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 |
| filingDate |
2016-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c935d6dd6e5fb16704a3365c22a1f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0fa9cba79a00ea74b6bb7582463b2c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5157e7e300bed5f97dc557512eab999f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e2a9bd7b1f05a3557e2584af10c501b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e53c8b5691ccee637bd4e90abf8f2dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786803e0303ac8c350efb2ac09428dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e00a176708db2a969e3287aa38f413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8fdfffa40a5d2554c18f7514eafe940
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c194d647a886fba23ef01b5181d9b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c196d50df1c72d1d8b610ff3fc103efc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_081a6380c8230feb13abc94e20a1bae0 |
| publicationDate |
2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11160855-B2 |
| titleOfInvention |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| abstract |
The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said novel immunogenic compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426456-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021196810-A1 |
| priorityDate |
2014-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |